Tci Wealth Advisors, Inc. Spectrum Pharmaceuticals Inc Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$0.32 - $0.52 $32 - $52	100 New	100 $0
Q3 2021 Oct 29, 2021	SELL	$2.15 - $3.82 $1,227 - $2,181	-571 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$2.89 - $4.45 $1,650 - $2,540	571 New	571 $2,000
Q1 2020 Apr 14, 2020	SELL	$1.83 - $3.45 $452 - $852	-247 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	247	247 $2,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.